lisinopril has been researched along with Xerostomia* in 2 studies
1 review(s) available for lisinopril and Xerostomia
Article | Year |
---|---|
Salivary function and hypertension: a review of the literature and a case report.
Limited evidence suggests a relationship between the use of antihypertensive medications and reduced salivary function. This article provides a review of the literature concerning the relationship between hypertension, hypertensive therapy and salivary function. A case report is presented to illustrate changes in salivary function in response to different types of antihypertensive medications. Topics: Humans; Hydrochlorothiazide; Hypertension; Lisinopril; Male; Middle Aged; Saliva; Secretory Rate; Xerostomia | 1995 |
1 other study(ies) available for lisinopril and Xerostomia
Article | Year |
---|---|
Oral Manifestations of Commonly Prescribed Drugs.
Drugs are being prescribed with more frequency and in higher quantities. A serious adverse drug event from prescribed medications constitutes 2.4% to 16.2% of all hospital admissions. Many of the adverse drug events present intraorally or periorally in isolation or as a clinical symptom of a systemic effect. Clinical recognition and treatment of adverse drug events are important to increase patient adherence, manage drug therapy, or detect early signs of potentially serious outcomes. Oral manifestations of commonly prescribed medications include gingival enlargement, oral hyperpigmentation, oral hypersensitivity reaction, medication-related osteonecrosis, xerostomia, and other oral or perioral conditions. To prevent dose-dependent adverse drug reactions, physicians should prescribe medications judiciously using the lowest effective dose with minimal duration. Alternatively, for oral hypersensitivity reactions that are not dose dependent, quick recognition of clinical symptoms associated with time-dependent drug onset can allow for immediate discontinuation of the medication without discontinuation of other medications. Physicians can manage oral adverse drug events in the office through oral hygiene instructions for gingival enlargement, medication discontinuation for oral pigmentation, and prescription of higher fluoride toothpastes for xerostomia. Topics: Albuterol; Amlodipine; Anticonvulsants; Antihypertensive Agents; Atorvastatin; Bisphosphonate-Associated Osteonecrosis of the Jaw; Bronchodilator Agents; Deprescriptions; Drug Hypersensitivity; Fluorides; Gingival Overgrowth; Humans; Hydroxymethylglutaryl-CoA Reductase Inhibitors; Hyperpigmentation; Hypoglycemic Agents; Lisinopril; Losartan; Metformin; Metoprolol; Mouth Diseases; Omeprazole; Oral Hygiene; Proton Pump Inhibitors; Simvastatin; Thyroxine; Toothpastes; Xerostomia | 2020 |